VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Technology Scientific & Technical Instruments

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by DeadliestCatchon Mar 02, 2017 10:05am

54 Views

Post# 25918555

RE:RE:World's First! $$$

Quality soft bash lol.

And ah now....HC approval is not a small feat.

eunice12 wrote: I'm kind of puzzled because anyone can get HC approval if their system works, which it always does or a company wouldn't apply. It is not like the FDA where scientists waste years for companies seeking approval, by trying to find some silly experiment for you to do that proves nothing new.
What I mean is a quick HC approval was a given before, so anyone who sold must have been light headed.

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?